Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NR3C1 | P04150 | 9/20 | 0.83 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.83 |
| ▸ | PGR | P06401 | 5/20 | 0.83 |
| ▸ | USP2 | O75604 | 3/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.80 |
| ▸ | MAPT | P10636 | 2/20 | 0.80 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.80 |
| ▸ | DRD2 | P14416 | 1/20 | 0.80 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.80 |
| ▸ | LMNA | P02545 | 3/20 | 0.72 |
| ▸ | HIF1A | Q16665 | 3/20 | 0.72 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.72 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.72 |
| ▸ | CNR1 | P21554 | 1/20 | 0.72 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.72 |
| ▸ | MLNR | O43193 | 1/20 | 0.71 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.71 |
| ▸ | CYP3A5 | P20815 | 1/20 | 0.71 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3021332 | 1.00 | NR3C1 (0.83) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL10797796 | 0.96 | NR3C1 (0.81) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL10797800 | 0.96 | NR3C1 (0.81) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL10797802 | 0.96 | NR3C1 (0.81) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL4888415 | 0.95 | NR3C1 (0.86) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL3021328 | 0.95 | NR3C1 (0.81) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL14867458 | 0.95 | NR3C1 (0.84) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL10866655 | 0.94 | NR3C1 (0.83) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL11520052 | 0.94 | NR3C1 (0.90) | NR3C1CYP3A4PGRUSP2MEN1 | |
| SCHEMBL10866663 | 0.94 | NR3C1 (0.83) | NR3C1CYP3A4PGRUSP2MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240423907-A1 | Improved Nasal Administration of Pharmaceutical Formulations | CYRANO THERAPEUTICS, INC. | 2024-12-26 | — | — | US | disclosed |
| EP-4460284-A1 | IMPROVED NASAL ADMINISTRATION OF PHARMACEUTICAL FORMULATIONS | Cyrano Therapeutics, Inc. (US) | 2024-11-13 | — | — | EP | disclosed |
| WO-2023133460-A1 | IMPROVED NASAL ADMINISTRATION OF PHARMACEUTICAL FORMULATIONS | CYRANO THERAPEUTICS, INC. (US) | 2023-07-13 | — | — | WO | disclosed |
| WO-2022049414-A1 | NITAZOXANIDE FOR USE TO TREAT COVID-19 | SIEGFRIED RHEIN, S.A. DE C.V. (MX) | 2022-03-10 | — | — | WO | disclosed |